Intuitive Surgical (ISRG) Price & Analysis

Compare

8,717 Followers

ISRG Stock Chart & Stats

$572.47

$11.55(2.17%)

At close: Jan 08 4:00 PM EST

$572.47

$11.55(2.17%)

Day’s Range― - ―

52-Week Range$425.00 - $616.00

Previous CloseN/A

Volume485.62K

Average Volume (3M)1.76M

Market Cap

$202.94B

Enterprise Value$157.01B

Total Cash (Recent Filing)$4.91B

Total Debt (Recent Filing)$0.00

Price to Earnings (P/E)75.8

Beta1.18

Next Earnings

Jan 22, 2026

EPS Estimate

2.25

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)2.40

Shares Outstanding354,496,060

10 Day Avg. Volume1,662,075

30 Day Avg. Volume1,757,680

Financial Highlights & Ratios

PEG Ratio2.88

Price to Book (P/B)11.28

Price to Sales (P/S)22.20

P/FCF Ratio142.20

Enterprise Value/Market Cap0.77

Enterprise Value/Revenue16.33

Enterprise Value/Gross Profit24.60

Enterprise Value/Ebitda43.84

Forecast

1Y Price Target

$624.28

Price Target Upside9.05% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering19

EPS Forecast (FY)8.65

Revenue Forecast (FY)$9.91B

Bulls Say, Bears Say

Bulls Say

Financial PerformanceExceptional Q3 from ISRG with beats across all key P&L lines, and EPS significantly ahead even adjusted for tax timing.

Market ExpansionStrong momentum is seen in expanding da Vinci programs internationally and moving procedures into ambulatory surgical centers in the U.S.

Product InnovationThe JURA System represents ISRG's type of innovation, aiming to improve standard of care, reduce variability in surgery, and achieve better outcomes.

Bears Say

Competitive ConcernsSentiment on ISRG shares shifted negative heading into the 3Q:25 print on potential for competition from Restore Robotics, shifting US capital spend outlook, and some degree of US saturation.

Reimbursement ChallengesESD reimbursement does not align well with the desired payback rate for robotic surgeries.

US-China Trade DisputeTariffs, capital environment, and competition remain key concerns that could influence capital and EPS outlooks as the US/China trade dispute continues.

Intuitive Surgical News

Intuitive Surgical price target raised to $650 from $620 at Truist

Truist raised the firm’s price target on Intuitive Surgical (ISRG) to $650 from $620 and keeps a Buy...

2d ago

ISRG

Intuitive Surgical price target raised to $650 from $625 at RBC Capital

RBC Capital analyst Shagun Singh raised the firm’s price target on Intuitive Surgical (ISRG) to $650 from $625...

3d ago

ISRG

Intuitive Surgical downgraded to Neutral from Buy at Citi

Citi downgraded Intuitive Surgical (ISRG) to Neutral from Buy with a price target of $635, down from $650....

9d ago

ISRG

Intuitive Surgical announces expanded indications for da Vinci Single Port

Intuitive announced that the FDA has cleared the da Vinci Single Port surgical system for use in inguinal...

10d ago

ISRG

China Flags Humanoid Robot Bubble Risk as Investor Hype Grows

China’s top economic-planning agency has issued a rare public warning about the risks of overheating in the country’s...

23d ago

SYM

EKSO

Intuitive Surgical Restructures Digital and AI Leadership Role

Intuitive Surgical ( ($ISRG) ) has shared an announcement. Effective January 1, 2026, Intuitive Surgical announced that Brian...

2d ago

ISRG

Intuitive Surgical Completes Key Study on Lung Biopsy Technology

Intuitive Surgical ($ISRG) announced an update on their ongoing clinical study. Study Overview: Intuitive Surgical recently completed a...

6d ago

ISRG

Intuitive Surgical: Buy Rating Backed by Innovative Imaging Technologies and Growth Potential

Travis Steed, an analyst from Bank of America Securities, maintained the Buy rating on Intuitive Surgical. The associated...

17d ago

ISRG

Intuitive Surgical: Strong Growth Potential and Strategic Positioning Drive Buy Rating

Lee Hambright, an analyst from Bernstein, maintained the Buy rating on Intuitive Surgical. The associated price target was...

1M ago

ISRG

Seaport biotech analysts hold an analyst/industry conference call

Biotech Analysts, along with ISRG Expert Steven Steinhardt and Dr. Steven Schwaitzberg, discuss robotic surgery procedure volumes, clinical...

1M ago

ISRG

Intuitive Surgical price target raised to $560 from $475 at Freedom Capital

Freedom Capital analyst Ilya Zubkov raised the firm’s price target on Intuitive Surgical (ISRG) to $560 from $475...

2M ago

ISRG

Intuitive Surgical Completes Study on Robotic Bronchoscopy System for Lung Cancer Diagnosis

Intuitive Surgical (($ISRG)) announced an update on their ongoing clinical study. Intuitive Surgical has recently completed a clinical...

2M ago

ISRG

Intuitive Surgical’s Stock Soars Amid Strong Performance

Intuitive Surgical ( ($ISRG) ) has risen by 19.20%. Read on to learn why. Intuitive Surgical has seen...

2M ago

ISRG

Top 3 Trending Stocks, According to Analysts – 10/23/2025

Wondering which stocks are trending today? TipRanks has calculated which stocks have received the greatest number of new...

2M ago

ISRG

NFLX

ISRG FAQ

What was Intuitive Surgical’s price range in the past 12 months?

Intuitive Surgical lowest stock price was $425.00 and its highest was $616.00 in the past 12 months.

What is Intuitive Surgical’s market cap?

Intuitive Surgical’s market cap is $202.94B.

When is Intuitive Surgical’s upcoming earnings report date?

Intuitive Surgical’s upcoming earnings report date is Jan 22, 2026 which is in 33 days.

How were Intuitive Surgical’s earnings last quarter?

Intuitive Surgical released its earnings results on Oct 21, 2025. The company reported $2.4 earnings per share for the quarter, beating the consensus estimate of $1.995 by $0.405.

Is Intuitive Surgical overvalued?

According to Wall Street analysts Intuitive Surgical’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Intuitive Surgical pay dividends?

Intuitive Surgical does not currently pay dividends.

What is Intuitive Surgical’s EPS estimate?

Intuitive Surgical’s EPS estimate is 2.25.

How many shares outstanding does Intuitive Surgical have?

Intuitive Surgical has 354,496,060 shares outstanding.

What happened to Intuitive Surgical’s price movement after its last earnings report?

Intuitive Surgical reported an EPS of $2.4 in its last earnings report, beating expectations of $1.995. Following the earnings report the stock price went up 13.893%.

Which hedge fund is a major shareholder of Intuitive Surgical?

Currently, no hedge funds are holding shares in ISRG

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Intuitive Surgical Stock Smart Score

Outperform

Fundamentals

Return on Equity

16.90%

Trailing 12-Months

Asset Growth

9.06%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical (ISRG) Earnings & Revenues

Historic Earnings Reports

ISRG Company Deck

ISRG Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call reflected strong growth in revenue, procedures, and technological advancements with successful international expansion and positive clinical outcomes. However, challenges persist in the Chinese market and domestic bariatric procedures decline, with some concerns over net placements.View all ISRG earnings summaries

ISRG Revenue Breakdown

66.92% U.S.

33.08% Outside of U.S

ISRG Stock 12 Month Forecast

Average Price Target

$624.28

▲(9.05% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"437":"$437","503":"$503","569":"$569","635":"$635","701":"$701"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":700,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$700.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":624.28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$624.28</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":540,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$540.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[437,503,569,635,701],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,567.37,577.5723076923077,587.7746153846153,597.9769230769231,608.1792307692308,618.3815384615384,628.5838461538461,638.7861538461539,648.9884615384615,659.1907692307692,669.3930769230769,679.5953846153845,689.7976923076923,{"y":700,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,567.37,571.7476923076923,576.1253846153846,580.503076923077,584.8807692307693,589.2584615384616,593.6361538461539,598.0138461538461,602.3915384615384,606.7692307692307,611.146923076923,615.5246153846153,619.9023076923077,{"y":624.28,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,567.37,565.2646153846154,563.1592307692308,561.0538461538462,558.9484615384615,556.843076923077,554.7376923076923,552.6323076923077,550.526923076923,548.4215384615385,546.3161538461538,544.2107692307692,542.1053846153847,{"y":540,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":542.85,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":521.96,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":571.88,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":573.15,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":496.36,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":517.18,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":553.29,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":537.99,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":483.12,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":469.07,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":438.04,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":534.28,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":567.37,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >